eHealth, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
EHTH$0.46+2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Table of Contents
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating activities: | ||
| Net loss | $(47,139) | $(87,425) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Depreciation and amortization | 1,384 | 1,481 |
| Amortization of internally developed software | 9,162 | 11,030 |
| Stock-based compensation expense | 11,587 | 15,125 |
| Deferred income taxes | (17,010) | (4,340) |
| Impairment charges | 868 | 7,413 |
| Other non-cash items | (596) | (43) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 14,955 | (1,871) |
| Contract assets – commissions receivable | 92,811 | 104,582 |
| Prepaid expenses and other assets | (7,661) | (9,896) |
| Accounts payable | (17,111) | (1,965) |
| Accrued compensation and benefits | (19,621) | (14,593) |
| Accrued marketing expenses | (11,054) | (11,132) |
| Deferred revenue | (872) | 861 |
| Accrued expenses and other liabilities | 901 | 69 |
| Net cash provided by operating activities | 10,604 | 9,296 |
| Investing activities: | ||
| Capitalized internal-use software and website development costs | (10,785) | (8,070) |
| Purchases of property and equipment and other assets | (2,107) | (1,463) |
| Purchases of marketable securities | (74,010) | (85,880) |
| Proceeds from redemption and maturities of marketable securities | 105,950 | 39,000 |
| Net cash provided by (used in) investing activities | 19,048 | (56,413) |
| Financing activities: | ||
| Payment of deferred financing costs | (1,000) | — |
| Net proceeds from exercise of common stock options and employee stock purchases | 189 | 354 |
| Repurchase of shares to satisfy employee tax withholding obligations | (2,102) | (2,301) |
| Principal payments in connection with leases | — | (4) |
| Payments of preferred stock dividends | (2,906) | (2,740) |
| Net cash used in financing activities | (5,819) | (4,691) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 59 | 118 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 23,892 | (51,690) |
| Cash, cash equivalents and restricted cash at beginning of period | 42,287 | 118,812 |
| Cash, cash equivalents and restricted cash at end of period | $66,179 | $67,122 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.